Emerald Health Biotechnology is Drug Discovery in Spain that focus on neurodegenerative diseases business. Founded in 2003. They cover business area such as developer, pharmaceutical drug, new non-psychotropic cannabinoid, inflammatory, disease, development, cannabidiol and cannabigerol chemical derivative, unmet clinical need, multiple sclerosis, scleroderma.
2003
( 21 years old in 2024 )
Neurodegenerative Diseases
-
Parque Científico Tecnológico de Córdoba (Rabanales 21)
Calle Astrónoma Cecilia Payne, Edificio Centauro, Planta 1
14014 Córdoba
Spain
Private
developerpharmaceutical drugnew non-psychotropic cannabinoidinflammatorydiseasedevelopmentcannabidiol and cannabigerol chemical derivativeunmet clinical needmultiple sclerosisscleroderma
* We use standard office opening hours in near Emerald Health Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Emerald Health Biotechnology is Drug Discovery business from Spain that founded in 2003 (21 years old in 2024), Emerald Health Biotechnology business is focusing on Neurodegenerative Diseases.
Emerald Health Biotechnology headquarter office and corporate office address is located in Parque Científico Tecnológico de Córdoba (Rabanales 21) Calle Astrónoma Cecilia Payne, Edificio Centauro, Planta 1 14014 Córdoba Spain.
Emerald Health Biotechnology was founded in Spain.
In 2024, Emerald Health Biotechnology is currently focus on neurodegenerative diseases sector.
Above is snippet of Google Trends for "neurodegenerative diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Emerald Health Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
